Zain Guduru

h-index

Research activity per year

If you made any changes in Pure these will be visible here soon.

Education/Academic qualification

Residency, Allegheny General Hospital. Pittsburgh, PA

2016

Bachelor of Medicine, Bachelor of Surgery, Rangaraya Medical College, INDIA

2009

Fingerprint

Dive into the research topics where Zain Guduru is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

1 Similar Profiles

1 Active
9 Finished

JZP385-202: A 17-week, Phase 2, Randomized, Double-blind, Placebo-controlled, Flexible-dosing, Parallel-group, Multicenter Study of the Efficacy and Safety of Suvecaltamide in the Treatment of Moderate to Severe Residual Tremor in Participants with Parkin
Guduru, Z.
Cavion Incorporated
8/17/23 → 8/17/25
Project: Research project
IRL790C005: A Randomized, Double-Blind, Placebo-Controlled, Phase IIb Study Evaluating the Efficacy of Mesdopetam on Daily ON-Time Without Troublesome Dyskinesia in Patients with Parkinson#s Disease
Guduru, Z.
Integrative Research Laboratories Sweden AB
5/27/21 → 2/28/23
Project: Research project
CVL-751-PD-004: 58-Week Open-label Trial of Tavapadon in Parkinson's Disease (TEMPO-4 Trial)
Guduru, Z.
Syneos Health LLC
12/10/20 → 5/2/23
Project: Research project
RAD-PD: Registry for the Advancement of DBS in Parkinson's Disease
Guduru, Z.
Neuropoint Alliance Incorporated
10/9/20 → 5/2/22
Project: Research project
CVL-751-PD-003: A Phase 3, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group, Flexible-Dose, 27-Week Trial to Evaluate the Efficacy, Safety, and Tolerability of Tavapadon as Adjunctive Therapy for Parkinson's Disease in Levodopa-Treated Adults
Guduru, Z.
Syneos Health LLC
8/3/20 → 10/12/23
Project: Research project

1 Article

Use of anti-TNF-alpha therapy in Crohn's disease is associated with increased incidence of multiple sclerosis
Avasarala, J., Guduru, Z., McLouth, CJ., Wilburn, A., Talbert, J., Sutton, P. & Sokola, BS., Jun 2021, In: Multiple Sclerosis and Related Disorders. 51, 6 p., 102942.
Research output: Contribution to journal › Article › peer-review

Resident Award
Guduru, Zain (Recipient), 2015
Prize: Honorary award

Zain Guduru

Personal profile

Education/Academic qualification

Fingerprint

Grants and Contracts

JZP385-202: A 17-week, Phase 2, Randomized, Double-blind, Placebo-controlled, Flexible-dosing, Parallel-group, Multicenter Study of the Efficacy and Safety of Suvecaltamide in the Treatment of Moderate to Severe Residual Tremor in Participants with Parkin

IRL790C005: A Randomized, Double-Blind, Placebo-Controlled, Phase IIb Study Evaluating the Efficacy of Mesdopetam on Daily ON-Time Without Troublesome Dyskinesia in Patients with Parkinson#s Disease

CVL-751-PD-004: 58-Week Open-label Trial of Tavapadon in Parkinson's Disease (TEMPO-4 Trial)

RAD-PD: Registry for the Advancement of DBS in Parkinson's Disease

CVL-751-PD-003: A Phase 3, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group, Flexible-Dose, 27-Week Trial to Evaluate the Efficacy, Safety, and Tolerability of Tavapadon as Adjunctive Therapy for Parkinson's Disease in Levodopa-Treated Adults

Research output

Use of anti-TNF-alpha therapy in Crohn's disease is associated with increased incidence of multiple sclerosis

Prizes

Resident Award